Litcius/Paper detail

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma

Julia E. Wiedmeier, Madiha Iqbal, Allison Rosenthal, Evandro D. Bezerra, Juan Esteban García-Robledo, Radhika Bansal, Patrick B. Johnston, Matthew Hathcock, Jeremy T. Larsen, P. Leif Bergsagel, Yucai Wang, Craig B. Reeder, José F. Leis, Rafaël Fonseca, Jeanne Palmer, Brianna J. Negaard, Raphael Mwangi, Rahma Warsame, Taxiarchis Kourelis, Suzanne R. Hayman, David Dingli, Prashant Kapoor, Shaji Kumar, Urshila Durani, José C. Villasboas, Jonas Paludo, N. Nora Bennani, Grzegorz S. Nowakowski, Stephen M. Ansell, Januario E. Castro, Mohamed A. Kharfan‐Dabaja, Yi Lin, Paschalis Vergidis, Hemant S. Murthy, Javier Muñoz

2023Clinical Lymphoma Myeloma & Leukemia27 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVaccinationSeroconversionLymphomaImmunologyMultiple myelomaAntibodyCancerChimeric antigen receptorImmune systemImmunotherapyVirologyInternal medicineCAR-T cell therapy researchViral Infectious Diseases and Gene Expression in InsectsBiosimilars and Bioanalytical Methods
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma | Litcius